Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Carbamazepine

3

I.c Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)

2
Last update : 20/01/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Anticonvulsants
3

Publications

Carbamazepine-induced interstitial pneumonitis in a lung transplant patient.
Respiratory medicine 2006 Sep;100;1660-2 2006 Sep
[Acute eosinophilic pneumonia due to hypersensitivity to carbamazepine].
Revue des maladies respiratoires 1998 Dec;15;797-9 1998 Dec
Carbamazepine and the lung.
The European respiratory journal 1990 Sep;3;930-1 1990 Sep
[Immuno-allergic side effects induced by the administration of carbamazepine. Case contribution].
Minerva medica 1984 Jun 30;75;1651-5 1984 Jun 30
Pulmonary eosinophilia associated with carbamazepine.
Archives of disease in childhood 1983 Oct;58;833-4 1983 Oct
Pulmonary eosinophilia and asthma associated with carbamazepine.
British medical journal (Clinical research ed.) 1981 Feb 07;282;440 1981 Feb 07
Acute hypersensitivity pneumonitis associated with carbamazepine therapy.
Chest 1978 Oct;74;463-4 1978 Oct
Acute pulmonary hypersensitivity to carbamazepine.
Chest 1975 Oct;68;580-1 1975 Oct

Powered by

  • ^
  • Contact
  • Cookies
  • About